| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 3349.76 | 99 |
| GSM780708 | Untreated after 4 days (C2_1) | 3891.52 | 99 |
| GSM780709 | Untreated after 4 days (C3_1) | 4470.41 | 99 |
| GSM780719 | Untreated after 4 days (C1_2) | 3472.29 | 99 |
| GSM780720 | Untreated after 4 days (C2_2) | 4260.43 | 99 |
| GSM780721 | Untreated after 4 days (C3_2) | 4664.72 | 99 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 3541.2 | 99 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 3394.94 | 99 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 2885.12 | 99 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 3745.12 | 99 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 3723.57 | 99 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 3301.02 | 99 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 3750.46 | 99 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 3468.99 | 99 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 3484.99 | 99 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 4019.75 | 99 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 3647.28 | 99 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 3891.52 | 99 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 4019.75 | 99 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 3860.35 | 99 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 3534.77 | 99 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 4042.24 | 99 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 4361.06 | 99 |